EMA Authorised: Ziihera (zanidatamab) — Jazz Pharmaceuticals Ireland Limited

View source ↗

Summary

ZaniDatamab (zanidatamab) has been authorised by EMA for biliary tract neoplasms with conditional approval and orphan designation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Neoplasms

Drugs mentioned

• ZIIHERA (ZANIDATAMAB-HRII)

Snippet

Status: Authorised. Therapeutic area: Biliary Tract Neoplasms. MAH: Jazz Pharmaceuticals Ireland Limited. Decision date: 21/05/2026. Conditional approval. Orphan medicine